Antiaging Properties of the Klotho Protein

Area of Science:

• Aging research
• Molecular biology
• Gerontology

Background:

• Mice lacking α-Klotho (Klotho) exhibit accelerated aging.
• The precise mechanisms linking Klotho deficiency to aging hallmarks are not fully understood.
• Aging is characterized by 12 key hallmarks, including chronic inflammation (inflammaging), DNA damage, and mitochondrial dysfunction.

Purpose of the Study:

• To investigate how Klotho deficiency impacts the 12 hallmarks of aging.
• To determine Klotho's protective roles against aging-related processes and diseases.
• To identify factors that influence Klotho levels for potential therapeutic interventions.

Main Methods:

• Analysis of aging hallmarks in Klotho-deficient mice.
• Examination of Klotho's effects on mitochondrial function, reactive oxygen species (ROS), and cellular senescence.
• Investigation of Klotho's inhibitory mechanisms against NF-κB and the NLRP3 inflammasome.
• Assessment of Klotho's impact on fibrosis, sarcopenia, and anti-cancer activity.

Main Results:

• Klotho ameliorates mitochondrial dysfunction, reduces ROS, and mitigates telomere attrition and cellular senescence.
• Klotho inhibits inflammaging, NF-κB, and the NLRP3 inflammasome, benefiting conditions like atherosclerosis, diabetes, and Alzheimer's disease.
• Klotho reduces organ fibrosis by inhibiting TGF-β and Wnt, protects against sarcopenia, and exhibits anti-cancer properties.

Conclusions:

• Klotho plays a crucial role in counteracting multiple aging hallmarks and age-related diseases.
• Maintaining adequate Klotho levels is vital for healthy aging and may be a therapeutic target.
• Further research into factors that increase Klotho could lead to novel clinical therapies for aging.